Prater
Adrian Prater, Richmond Hill CA
Patent application number | Description | Published |
---|---|---|
20090100743 | Device for Illumination and Insect Extermination - A device for illumination and insect extermination for use with a conventional electrical wall outlet features a light source and an electrocution grid both operatively connected to electrical connectors through which power is supplied. The light source and grid are arranged such that the grid does not interfere with the transmission of light in at least one direction. A housing and a perforated translucent guard positioned about the light source and grid allow a substantial portion of the light emitted to leave the device while preventing accidental human contact with the electrocution grid. A switch allows the grid to be manually disabled while removal of the guard causes automatic disabling. A photoelectric sensor prevents wasteful energy use by activating the light source only when the surrounding environment is substantially dark. | 04-23-2009 |
Derek Prater, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20110104214 | ONCE-A-DAY OXYCODONE FORMULATIONS - The invention is directed to sustained release formulations containing oxycodone or a pharmaceutically acceptable salt thereof which provide a mean C | 05-05-2011 |
Derek Prater, Cambridgeshire GB
Derek A. Prater, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20100087470 | Buprenorphine-Wafer for Drug Substitution Therapy - The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects. | 04-08-2010 |
20150025102 | Buprenorphine-Wafer for Drug Substitution Therapy - The present invention relates to oral pharmaceutical dosage forms comprising buprenorphine with the dosage form releasing buprenorphine instantly upon oral, preferably sublingual, application of the dosage form. The present invention also relates to the use of such dosage forms for treating pain in a human or animal or for drug substitution therapy in drug-dependent human subjects. | 01-22-2015 |
Derek Allan Prater, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20090117191 | Controlled release tramadol formulations - A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient. | 05-07-2009 |
Derek Allan Prater, Milton GB
Patent application number | Description | Published |
---|---|---|
20090029170 | EXTRUSION - The invention relates to a process for preparing a controlled release pharmaceutical extrudate using a melt extruder, | 01-29-2009 |
Derek Allan Prater, Milton Cambridge GB
Patent application number | Description | Published |
---|---|---|
20130245054 | USE OF BINDERS FOR MANUFACTURING STORAGE STABLE FORMULATIONS - The present invention relates to storage stable prolonged release pharmaceutical dosage forms comprising oxycodone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof, the manufacture thereof as well as their use for administration to human beings. | 09-19-2013 |